BVS vs DD · rev $573.3M vs P/E 127, rev $12.39B
Bioventus Inc (BVS) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
BVS currently screens at market cap $495.1M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the BVS and DD stock pages for the full models.
Not investment advice.